BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30103800)

  • 21. DNA Damage Response After Ionizing Radiation Exposure in Skin Keratinocytes Derived from Human-Induced Pluripotent Stem Cells.
    Miyake T; Shimada M; Matsumoto Y; Okino A
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):193-205. PubMed ID: 31085283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.
    Wenzel D; Bayerl J; Nyström A; Bruckner-Tuderman L; Meixner A; Penninger JM
    Sci Transl Med; 2014 Nov; 6(264):264ra165. PubMed ID: 25429058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of keratinocytic phenotypes in autonomous trisomy-rescued cells.
    Tanuma-Takahashi A; Inoue M; Kajiwara K; Takagi R; Yamaguchi A; Samura O; Akutsu H; Sago H; Kiyono T; Okamoto A; Umezawa A
    Stem Cell Res Ther; 2021 Aug; 12(1):476. PubMed ID: 34433490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomes Secreted from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Accelerate Skin Cell Proliferation.
    Kim S; Lee SK; Kim H; Kim TM
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of mouse induced pluripotent stem cells into a multipotent keratinocyte lineage.
    Bilousova G; Chen J; Roop DR
    J Invest Dermatol; 2011 Apr; 131(4):857-64. PubMed ID: 21150926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment and gene expression analysis of disease-derived induced pluripotent stem cells of scleroderma.
    Wang Z; Nakamura K; Jinnin M; Kudo H; Goto M; Era T; Kira T; Nakashima T; Fukushima S; Ihn H
    J Dermatol Sci; 2016 Nov; 84(2):186-196. PubMed ID: 27510999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supporting materials: Endothelial cells differentiated from patient dermal fibroblast-derived induced pluripotent stem cells resemble vascular malformations of Port Wine Birthmark.
    Nguyen V; Gao C; Hochman ML; Kravitz J; Chen EH; Friedman HI; Wenceslau CF; Chen D; Wang Y; Nelson JS; Jegga AG; Tan W
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of Three-Dimensional Skin From Human-Induced Pluripotent Stem Cells as a Tool to Evaluate Transdermal Drug Permeation.
    Naito C; Yamaguchi T; Katsumi H; Kimura S; Kamei S; Morishita M; Sakane T; Kawabata K; Yamamoto A
    J Pharm Sci; 2019 Nov; 108(11):3524-3527. PubMed ID: 31351104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of functional neurons from feeder-free, keratinocyte-derived equine induced pluripotent stem cells.
    Sharma R; Livesey MR; Wyllie DJ; Proudfoot C; Whitelaw CB; Hay DC; Donadeu FX
    Stem Cells Dev; 2014 Jul; 23(13):1524-34. PubMed ID: 24548115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
    Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
    Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
    Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
    BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature.
    Park TS; Bhutto I; Zimmerlin L; Huo JS; Nagaria P; Miller D; Rufaihah AJ; Talbot C; Aguilar J; Grebe R; Merges C; Reijo-Pera R; Feldman RA; Rassool F; Cooke J; Lutty G; Zambidis ET
    Circulation; 2014 Jan; 129(3):359-72. PubMed ID: 24163065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of diabetic foot ulcer-derived induced pluripotent stem cells reveals distinct cellular and tissue phenotypes.
    Kashpur O; Smith A; Gerami-Naini B; Maione AG; Calabrese R; Tellechea A; Theocharidis G; Liang L; Pastar I; Tomic-Canic M; Mooney D; Veves A; Garlick JA
    FASEB J; 2019 Jan; 33(1):1262-1277. PubMed ID: 30088952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
    Galach M; Utikal J
    Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Origin-dependent neural cell identities in differentiated human iPSCs in vitro and after transplantation into the mouse brain.
    Hargus G; Ehrlich M; Araúzo-Bravo MJ; Hemmer K; Hallmann AL; Reinhardt P; Kim KP; Adachi K; Santourlidis S; Ghanjati F; Fauser M; Ossig C; Storch A; Kim JB; Schwamborn JC; Sterneckert J; Schöler HR; Kuhlmann T; Zaehres H
    Cell Rep; 2014 Sep; 8(6):1697-1703. PubMed ID: 25220454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reprogramming human dermal fibroblast into induced pluripotent stem cells using nonintegrative Sendai virus for transduction.
    Tai L; Teoh HK; Cheong SK
    Malays J Pathol; 2018 Dec; 40(3):325-329. PubMed ID: 30580364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer cells as a new source of induced pluripotent stem cells.
    Shamsian A; Sahebnasagh R; Norouzy A; Hussein SH; Ghahremani MH; Azizi Z
    Stem Cell Res Ther; 2022 Sep; 13(1):459. PubMed ID: 36064437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.